Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates

Journal of Nuclear Medicine

Volumn 38, Issue 1, 1997, Pages 133-138

  Ultee, Michiel E ^b   Bridger, Gary J ^b   Abrams, Michael J ^a   Longley, Clifford B ^b   Burton, Charlotte A ^b   Larsen, Scott K ^b   Henson, Geoffrey W ^b   Padmanabhan, Sreenivasan ^b   Gaul, Forrest E ^b   Schwartz, David A ^b  

^a Anor MED Inc   (Canada)

^b NONE

Author keywords

antibody fragments; cancer imaging; immunoscintigraphy; technetium 99m

Indexed keywords

BROMOACETYLHYDRAZINONICOTINAMIDE HYDROBROMIDE; IMMUNOGLOBULIN F(AB) FRAGMENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG CLEARANCE; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; ISOTOPE LABELING; MICE; MICE, NUDE; NIACINAMIDE; TECHNETIUM;

EID: 0031030645     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. 99m-labelled monoclonal antibodies: influence of technetium-99m binding sites. J Nucl Med 1994;35:876-881.
2. 99mTc-labeled monoclonal antibodies: a review. Nucl Med Commun 1993;14:347-359.
3. Abrams MJ, Juweid M, Tenkate CI, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990;31:2022-2028.
4. 99mTc-protein conjugates. Bioconj Chem 1991;2:333-336.
5. 1 for thrombus imaging. J Nucl Med 1992;33:710-715.
6. Hnatowich DJ, Mardirossian G, Rusckowski M, Forgarasi M, Virzi F, Winnard P. Directly and indirectly technetium-99m-labeled antibodies. A comparison of in vitro and animal in vivo properties. J Nucl Med 1993;34:109-119.
7. Babich JW, Solomon H, Pike MC, Kroon D, et al. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J Nucl Med 1993;34:1964-1974.
8. Armitage NC, Perkins AC, Durran LG, et al. In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcinoembryonic antigen. Br J Surg 1986;73:965.
9. White CA, Dulbecco R, Allen R, Bowman M, Armstrong B. Two monoclonal antibodies selective for human mammary carcinoma. Cancer Res 1985;45:1337-1343.
10. Rea RW, Ultee ME. A novel method for controlling the pepsin digestion of antibodies. J Immunol Methods 1993;157:165-173.
11. Grassetti DR, Murray JF Jr. Determination of sulfhydryl groups with 2,2′ or 4,4′ dithiodipyridine. Archiv Biochem Biophys 1967;119:41-49.
12. Larsen SK, Solomon HF, Caldwell G, Abrams MJ. Technetium-99m-tricine: A useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconj Chem 1995;6:635-638.
13. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Met 1984;72:777-789.
14. 111In-labeled monoclonal antibodies using nude mouse zenograft systems. In: Rodwell JD, ed. Covalent modification of monoclonal antibodies, New York: Marcel Decker; 1988:283.
15. Rosenstraus MJ, Davis WL, Lopes AD, D'Aleo CJ, Gilman SC. Immunohistochemical and pharmacokinetic characterization of site-specific immunoconjugate 15A8-glycyltyrosyl-(N-∈-diethylcne pentaacetic acid)-lysine derived from anti-breast carcinoma monoclonal antibody 15A8. Cancer Res 1991;51:5744-5751.
16. Rhodes BA, Buckelew JM, Pant KD, Hinkle GH. Quality control test for immunoreactivity of radiolabeled antibody. Biotechniques 1990;8:70-73.
17. Bridger GJ, Abrams MJ, Padmanabhan S, et al. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the technetium-99m labeling of Fab′ monoclonal antibody fragments. Bioconj Chem 1996;7:255-264.
18. Paik CH, Yokoyama K, Reynolds, JC, et al. Reduction of background activities by introduction of a diester linkage between antibody and chelate in radioimmunodetection of tumor. J Nucl Med 1989;30:1693-1701.
19. 99mTc-radiolabelled antibody Fab′-chelator conjugate. Bioconj Chem 1990;1:431-437.
20. Deshapande SV, DeNardo SJ, Meares CF, McCall MJ, Adams GP, DeNardo GL. Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Nucl Med Biol 1989;16:587-597.
21. Solomon HF, Jester D, Rauh D, et al. A comparison of Tc-99m-SHNH labeled IgG, Tc-99m-HIG Technescan and In-111 Macroscint DTPA-IgG in a rat model of focal infection [Abstract]. J Nucl Med 1993;34(suppl):174P.
22. Pimm MV, Gribben SJ. Prevention of renal tubule re-absorption of radiometal indium-111-labeled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur J Nucl Med 1994;21:663-665.
23. Hammond PH, Wade AF, Gwilliam ME, et al. Amino acid infusion blocks renal tubule uptake of indium-labeled somatostatin analog. Br J Cancer 1993;67:1437-1439.